The use of nucleic acid nanostructures for RNAi delivery is an innovative approach in gene therapy. These nanostructures enhance the stability and targeting efficiency of RNA interference molecules, facilitating their delivery to specific cells. By designing nanostructures that optimize pharmacokinetics and minimize immune responses, researchers can significantly improve therapeutic outcomes in various diseases, including genetic disorders and cancers.